Randomized controlled clinical trials are considered the gold standard for understanding treatment safety and efficacy. Rare disease trials struggle to recruit enough participants to demonstrate efficacy, creating a barrier to research and approval. However, Bayesian statistics utilize existing evidence and expert opinion to quantify uncertainty and inform trial design, reducing necessary sample size.
